Healthcare

PRODUCTS

  • By combining purpose-built polymers and lipids, animal-origin-free reagents seamlessly blend into the AAV manufacturing process during transfection to dramatically increase AAV titers.

  • There are clearly defined pathways for drug approval, and choosing the right regulatory pathway for your drug development program requires a thorough understanding of sections 505(b)(1) and 505(b)(2) of the Federal Food, Drug, and Cosmetics (FD&C) Act.

  • Zelta’s EDC has been used in more than 4,000 studies from startup to submission, across all phases, including over 500 phase 3c trials and 23 therapeutic areas.

  • Streamline Your Media Preparation and Column Packing

    At Asahi Kasei Bioprocess, we understand the importance of efficient and reliable slurry preparation for successful purification processes. With that in mind, we have developed the SLURIPREP line of media management products to simplify your resin preparation and packing, specifically designed for DAC LC Columns. Our comprehensive range of accessories ensures that your column operation is seamless, efficient, and optimized for high productivity.

  • Developing a therapy for a rare or ultra-rare disease is life-changing work with unique challenges. Examine how natural history data is being used to inform the clinical development process.

WHITE PAPERS AND CASE STUDIES

NEWS